Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used.

Bossuyt X, Delforge M, Reynders M, Dillaerts D, Sprangers B, Fostier K, Poesen K, Vercammen M.

Leukemia. 2017 Nov 20. doi: 10.1038/leu.2017.335. [Epub ahead of print]


Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.

De Veirman K, De Beule N, Maes K, Menu E, De Bruyne E, De Raeve H, Fostier K, Moreaux J, Kassambara A, Hose D, Heusschen R, Eriksson H, Vanderkerken K, Van Valckenborgh E.

Cancer Immunol Res. 2017 Oct;5(10):839-846. doi: 10.1158/2326-6066.CIR-17-0192. Epub 2017 Sep 13.


Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.

Demeulenaere M, Duerinck J, DU Four S, Fostier K, Michotte A, Neyns B.

Anticancer Res. 2016 Aug;36(8):4145-9.


An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration.

Spapen J, Fostier K, De Raeve H, Janssens P, Spapen H.

Int J Nephrol Renovasc Dis. 2015 Dec 21;9:1-4. doi: 10.2147/IJNRD.S98528. eCollection 2016.


Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.

Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, Fostier K, Kassambara A, Moreaux J, Hose D, Leleu X, King RW, Vanderkerken K, Van Valckenborgh E.

Oncotarget. 2016 Jan 26;7(4):4062-76. doi: 10.18632/oncotarget.6768.


Cellular immunotherapy in multiple myeloma: lessons from preclinical models.

Binsfeld M, Fostier K, Muller J, Baron F, Schots R, Beguin Y, Heusschen R, Caers J.

Biochim Biophys Acta. 2014 Dec;1846(2):392-404. doi: 10.1016/j.bbcan.2014.08.001. Epub 2014 Aug 7. Review.


The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic.

Bieghs L, Lub S, Fostier K, Maes K, Van Valckenborgh E, Menu E, Johnsen HE, Overgaard MT, Larsson O, Axelson M, Nyegaard M, Schots R, Jernberg-Wiklund H, Vanderkerken K, De Bruyne E.

Oncotarget. 2014 Nov 30;5(22):11193-208.


Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation.

De Keersmaecker B, Fostier K, Corthals J, Wilgenhof S, Heirman C, Aerts JL, Thielemans K, Schots R.

Cancer Immunol Immunother. 2014 Oct;63(10):1023-36. doi: 10.1007/s00262-014-1571-6. Epub 2014 Jun 20.


Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model.

Nur H, Fostier K, Aspeslagh S, Renmans W, Bertrand E, Leleu X, Favreau M, Breckpot K, Schots R, De Waele M, Van Valckenborgh E, De Bruyne E, Facon T, Elewaut D, Vanderkerken K, Menu E.

PLoS One. 2013 May 31;8(5):e65075. doi: 10.1371/journal.pone.0065075. Print 2013.


miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.

Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C, De Grève J.

PLoS One. 2013;8(3):e60317. doi: 10.1371/journal.pone.0060317. Epub 2013 Mar 26.


Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma.

Fostier K, De Becker A, Schots R.

Onco Targets Ther. 2012;5:237-44. doi: 10.2147/OTT.S28911. Epub 2012 Sep 28.


Systemic anaplastic large cell lymphoma presenting with cutaneous manifestations in a young man: a case report.

Vande Walle N, Van den Enden E, Fostier K, De Coninck A, Nieboer K, Velkeniers B, Lacor P.

Acta Clin Belg. 2012 Mar-Apr;67(2):127-9.


Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA.

Bonehill A, Tuyaerts S, Van Nuffel AM, Heirman C, Bos TJ, Fostier K, Neyns B, Thielemans K.

Mol Ther. 2008 Jun;16(6):1170-80. doi: 10.1038/mt.2008.77. Epub 2008 Apr 22.


An unusual case of hyperglycemia, abdominal pain, and increased anion gap acidosis.

Vermeersch N, Stolte C, Fostier K, Delooz H.

J Emerg Med. 2010 Oct;39(4):449-53. doi: 10.1016/j.jemermed.2007.11.004. Epub 2008 Feb 14.


Supplemental Content

Loading ...
Support Center